Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

7.74
Delayed Data
As of Sep 04
 +0.19 / +2.52%
Today’s Change
6.71
Today|||52-Week Range
16.87
-36.82%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close7.55
Today’s open7.42
Day’s range7.35 - 7.76
Volume2,452,391
Average volume (3 months)2,532,523
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+50.71%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.59

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...+0.07+0.55%
DVAXDynavax Technologies...+0.45+1.62%
RGENRepligen Corp-0.41-1.22%
MACKMerrimack Pharmaceut...-0.32-3.14%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

Partner Offers